Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Operating Expenses | 12,633 | 13,028 | 14,338 | 21,441 | 20,693 |
| Operating Income | -12,633 | -13,028 | -14,338 | -21,441 | -20,693 |
| Other Income | 2,390 | -14,670 | 1,769 | 2,006 | 2,141 |
| Pre-tax Income | -10,243 | -27,698 | -12,568 | -19,435 | -18,552 |
| Net Income Continuous | -10,243 | -27,698 | -12,568 | -19,435 | -18,552 |
| Net Income | $-10,243 | $-27,698 | $-12,568 | $-19,435 | $-18,552 |
| EPS Basic Total Ops | -0.06 | -0.22 | -0.11 | -0.19 | -0.37 |
| EPS Basic Continuous Ops | -0.06 | -0.21 | -0.11 | -0.18 | -0.24 |
| EPS Diluted Total Ops | -0.06 | -0.22 | -0.11 | -0.19 | -0.37 |
| EPS Diluted Continuous Ops | -0.06 | -0.21 | -0.11 | -0.18 | -0.24 |
| EBITDA(a) | $-11,953 | $-12,351 | $-13,660 | $-20,762 | $-20,013 |